2018-2023 Global Anticancer Drugs Consumption Market Report

August 2018 | 133 pages | ID: 201E8A4778AEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Anticancer Drugs market for 2018-2023.
Antineoplastic drugs, also known as anticancer drugs, anti-malignant drugs, refer to drugs for the treatment of malignant tumors.
Simply put, there are chemotherapy drugs and biological agents. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of tumors; the invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry, and genetic engineering have accelerated the process of drug development; research and development of anti-tumor drugs have been Enter a new era.
At present, there are more than 80 kinds of anti-cancer drugs commonly used in clinical practice in the world, which can be roughly divided into the following 6 categories: cytotoxic drugs, hormone drugs, biological response modifiers, monoclonal antibody drugs, other drugs, and auxiliary drugs.

Over the next five years, LPI(LP Information) projects that Anticancer Drugs will register a 8.0% CAGR in terms of revenue, reach US$ 141900 million by 2023, from US$ 89300 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Anticancer Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
• Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
• Hormonal Drugs

Segmentation by application:

• Lung Cancer
• Breast Cancer
• Leukemia
• Colorectal Cancer

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• F. Hoffmann-La Roche Ltd
• Eli Lilly and Company
• CELGENE CORPORATION
• Novartis AG
• Pfizer Inc
• Amgen Inc
• Bayer AG
• AstraZeneca
• Takeda Pharmaceutical Company Limited
• Merck & Co.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Anticancer Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Anticancer Drugs market by identifying its various subsegments.
• Focuses on the key global Anticancer Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Anticancer Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Anticancer Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL ANTICANCER DRUGS CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Anticancer Drugs Consumption 2013-2023
  2.1.2 Anticancer Drugs Consumption CAGR by Region
2.2 Anticancer Drugs Segment by Type
  2.2.1 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
  2.2.2 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
  2.2.3 Hormonal Drugs
2.3 Anticancer Drugs Consumption by Type
  2.3.1 Global Anticancer Drugs Consumption Market Share by Type (2013-2018)
  2.3.2 Global Anticancer Drugs Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Anticancer Drugs Sale Price by Type (2013-2018)
2.4 Anticancer Drugs Segment by Application
  2.4.1 Lung Cancer
  2.4.2 Breast Cancer
  2.4.3 Leukemia
  2.4.4 Colorectal Cancer
2.5 Anticancer Drugs Consumption by Application
  2.5.1 Global Anticancer Drugs Consumption Market Share by Application (2013-2018)
  2.5.2 Global Anticancer Drugs Value and Market Share by Application (2013-2018)
  2.5.3 Global Anticancer Drugs Sale Price by Application (2013-2018)

3 GLOBAL ANTICANCER DRUGS BY PLAYERS

3.1 Global Anticancer Drugs Sales Market Share by Players
  3.1.1 Global Anticancer Drugs Sales by Players (2016-2018)
  3.1.2 Global Anticancer Drugs Sales Market Share by Players (2016-2018)
3.2 Global Anticancer Drugs Revenue Market Share by Players
  3.2.1 Global Anticancer Drugs Revenue by Players (2016-2018)
  3.2.2 Global Anticancer Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Anticancer Drugs Sale Price by Players
3.4 Global Anticancer Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Anticancer Drugs Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Anticancer Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ANTICANCER DRUGS BY REGIONS

4.1 Anticancer Drugs by Regions
  4.1.1 Global Anticancer Drugs Consumption by Regions
  4.1.2 Global Anticancer Drugs Value by Regions
4.2 Americas Anticancer Drugs Consumption Growth
4.3 APAC Anticancer Drugs Consumption Growth
4.4 Europe Anticancer Drugs Consumption Growth
4.5 Middle East & Africa Anticancer Drugs Consumption Growth

5 AMERICAS

5.1 Americas Anticancer Drugs Consumption by Countries
  5.1.1 Americas Anticancer Drugs Consumption by Countries (2013-2018)
  5.1.2 Americas Anticancer Drugs Value by Countries (2013-2018)
5.2 Americas Anticancer Drugs Consumption by Type
5.3 Americas Anticancer Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Anticancer Drugs Consumption by Countries
  6.1.1 APAC Anticancer Drugs Consumption by Countries (2013-2018)
  6.1.2 APAC Anticancer Drugs Value by Countries (2013-2018)
6.2 APAC Anticancer Drugs Consumption by Type
6.3 APAC Anticancer Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Anticancer Drugs by Countries
  7.1.1 Europe Anticancer Drugs Consumption by Countries (2013-2018)
  7.1.2 Europe Anticancer Drugs Value by Countries (2013-2018)
7.2 Europe Anticancer Drugs Consumption by Type
7.3 Europe Anticancer Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Anticancer Drugs by Countries
  8.1.1 Middle East & Africa Anticancer Drugs Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Anticancer Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Anticancer Drugs Consumption by Type
8.3 Middle East & Africa Anticancer Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Anticancer Drugs Distributors
10.3 Anticancer Drugs Customer

11 GLOBAL ANTICANCER DRUGS MARKET FORECAST

11.1 Global Anticancer Drugs Consumption Forecast (2018-2023)
11.2 Global Anticancer Drugs Forecast by Regions
  11.2.1 Global Anticancer Drugs Forecast by Regions (2018-2023)
  11.2.2 Global Anticancer Drugs Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Anticancer Drugs Forecast by Type
11.8 Global Anticancer Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 F. Hoffmann-La Roche Ltd
  12.1.1 Company Details
  12.1.2 Anticancer Drugs Product Offered
  12.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 F. Hoffmann-La Roche Ltd News
12.2 Eli Lilly and Company
  12.2.1 Company Details
  12.2.2 Anticancer Drugs Product Offered
  12.2.3 Eli Lilly and Company Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Eli Lilly and Company News
12.3 CELGENE CORPORATION
  12.3.1 Company Details
  12.3.2 Anticancer Drugs Product Offered
  12.3.3 CELGENE CORPORATION Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 CELGENE CORPORATION News
12.4 Novartis AG
  12.4.1 Company Details
  12.4.2 Anticancer Drugs Product Offered
  12.4.3 Novartis AG Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Novartis AG News
12.5 Pfizer Inc
  12.5.1 Company Details
  12.5.2 Anticancer Drugs Product Offered
  12.5.3 Pfizer Inc Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Pfizer Inc News
12.6 Amgen Inc
  12.6.1 Company Details
  12.6.2 Anticancer Drugs Product Offered
  12.6.3 Amgen Inc Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Amgen Inc News
12.7 Bayer AG
  12.7.1 Company Details
  12.7.2 Anticancer Drugs Product Offered
  12.7.3 Bayer AG Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Bayer AG News
12.8 AstraZeneca
  12.8.1 Company Details
  12.8.2 Anticancer Drugs Product Offered
  12.8.3 AstraZeneca Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 AstraZeneca News
12.9 Takeda Pharmaceutical Company Limited
  12.9.1 Company Details
  12.9.2 Anticancer Drugs Product Offered
  12.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Takeda Pharmaceutical Company Limited News
12.10 Merck & Co.
  12.10.1 Company Details
  12.10.2 Anticancer Drugs Product Offered
  12.10.3 Merck & Co. Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Merck & Co. News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anticancer Drugs
Table Product Specifications of Anticancer Drugs
Figure Anticancer Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Anticancer Drugs Consumption Growth Rate 2013-2023 (K Units)
Figure Global Anticancer Drugs Value Growth Rate 2013-2023 ($ Millions)
Table Anticancer Drugs Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Table Major Players of Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Figure Product Picture of Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Table Major Players of Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Figure Product Picture of Hormonal Drugs
Table Major Players of Hormonal Drugs
Table Global Consumption Sales by Type (2013-2018)
Table Global Anticancer Drugs Consumption Market Share by Type (2013-2018)
Figure Global Anticancer Drugs Consumption Market Share by Type (2013-2018)
Table Global Anticancer Drugs Revenue by Type (2013-2018) ($ million)
Table Global Anticancer Drugs Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Anticancer Drugs Value Market Share by Type (2013-2018)
Table Global Anticancer Drugs Sale Price by Type (2013-2018)
Figure Anticancer Drugs Consumed in Lung Cancer
Figure Global Anticancer Drugs Market: Lung Cancer (2013-2018) (K Units)
Figure Global Anticancer Drugs Market: Lung Cancer (2013-2018) ($ Millions)
Figure Global Lung Cancer YoY Growth ($ Millions)
Figure Anticancer Drugs Consumed in Breast Cancer
Figure Global Anticancer Drugs Market: Breast Cancer (2013-2018) (K Units)
Figure Global Anticancer Drugs Market: Breast Cancer (2013-2018) ($ Millions)
Figure Global Breast Cancer YoY Growth ($ Millions)
Figure Anticancer Drugs Consumed in Leukemia
Figure Global Anticancer Drugs Market: Leukemia (2013-2018) (K Units)
Figure Global Anticancer Drugs Market: Leukemia (2013-2018) ($ Millions)
Figure Global Leukemia YoY Growth ($ Millions)
Figure Anticancer Drugs Consumed in Colorectal Cancer
Figure Global Anticancer Drugs Market: Colorectal Cancer (2013-2018) (K Units)
Figure Global Anticancer Drugs Market: Colorectal Cancer (2013-2018) ($ Millions)
Figure Global Colorectal Cancer YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Anticancer Drugs Consumption Market Share by Application (2013-2018)
Figure Global Anticancer Drugs Consumption Market Share by Application (2013-2018)
Table Global Anticancer Drugs Value by Application (2013-2018)
Table Global Anticancer Drugs Value Market Share by Application (2013-2018)
Figure Global Anticancer Drugs Value Market Share by Application (2013-2018)
Table Global Anticancer Drugs Sale Price by Application (2013-2018)
Table Global Anticancer Drugs Sales by Players (2016-2018) (K Units)
Table Global Anticancer Drugs Sales Market Share by Players (2016-2018)
Figure Global Anticancer Drugs Sales Market Share by Players in 2016
Figure Global Anticancer Drugs Sales Market Share by Players in 2017
Table Global Anticancer Drugs Revenue by Players (2016-2018) ($ Millions)
Table Global Anticancer Drugs Revenue Market Share by Players (2016-2018)
Figure Global Anticancer Drugs Revenue Market Share by Players in 2016
Figure Global Anticancer Drugs Revenue Market Share by Players in 2017
Table Global Anticancer Drugs Sale Price by Players (2016-2018)
Figure Global Anticancer Drugs Sale Price by Players in 2017
Table Global Anticancer Drugs Manufacturing Base Distribution and Sales Area by Players
Table Players Anticancer Drugs Products Offered
Table Anticancer Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Anticancer Drugs Consumption by Regions 2013-2018 (K Units)
Table Global Anticancer Drugs Consumption Market Share by Regions 2013-2018
Figure Global Anticancer Drugs Consumption Market Share by Regions 2013-2018
Table Global Anticancer Drugs Value by Regions 2013-2018 ($ Millions)
Table Global Anticancer Drugs Value Market Share by Regions 2013-2018
Figure Global Anticancer Drugs Value Market Share by Regions 2013-2018
Figure Americas Anticancer Drugs Consumption 2013-2018 (K Units)
Figure Americas Anticancer Drugs Value 2013-2018 ($ Millions)
Figure APAC Anticancer Drugs Consumption 2013-2018 (K Units)
Figure APAC Anticancer Drugs Value 2013-2018 ($ Millions)
Figure Europe Anticancer Drugs Consumption 2013-2018 (K Units)
Figure Europe Anticancer Drugs Value 2013-2018 ($ Millions)
Figure Middle East & Africa Anticancer Drugs Consumption 2013-2018 (K Units)
Figure Middle East & Africa Anticancer Drugs Value 2013-2018 ($ Millions)
Table Americas Anticancer Drugs Consumption by Countries (2013-2018) (K Units)
Table Americas Anticancer Drugs Consumption Market Share by Countries (2013-2018)
Figure Americas Anticancer Drugs Consumption Market Share by Countries in 2017
Table Americas Anticancer Drugs Value by Countries (2013-2018) ($ Millions)
Table Americas Anticancer Drugs Value Market Share by Countries (2013-2018)
Figure Americas Anticancer Drugs Value Market Share by Countries in 2017
Table Americas Anticancer Drugs Consumption by Type (2013-2018) (K Units)
Table Americas Anticancer Drugs Consumption Market Share by Type (2013-2018)
Figure Americas Anticancer Drugs Consumption Market Share by Type in 2017
Table Americas Anticancer Drugs Consumption by Application (2013-2018) (K Units)
Table Americas Anticancer Drugs Consumption Market Share by Application (2013-2018)
Figure Americas Anticancer Drugs Consumption Market Share by Application in 2017
Figure United States Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure United States Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Figure Canada Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure Canada Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Figure Mexico Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure Mexico Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Table APAC Anticancer Drugs Consumption by Countries (2013-2018) (K Units)
Table APAC Anticancer Drugs Consumption Market Share by Countries (2013-2018)
Figure APAC Anticancer Drugs Consumption Market Share by Countries in 2017
Table APAC Anticancer Drugs Value by Countries (2013-2018) ($ Millions)
Table APAC Anticancer Drugs Value Market Share by Countries (2013-2018)
Figure APAC Anticancer Drugs Value Market Share by Countries in 2017
Table APAC Anticancer Drugs Consumption by Type (2013-2018) (K Units)
Table APAC Anticancer Drugs Consumption Market Share by Type (2013-2018)
Figure APAC Anticancer Drugs Consumption Market Share by Type in 2017
Table APAC Anticancer Drugs Consumption by Application (2013-2018) (K Units)
Table APAC Anticancer Drugs Consumption Market Share by Application (2013-2018)
Figure APAC Anticancer Drugs Consumption Market Share by Application in 2017
Figure China Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure China Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Figure Japan Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure Japan Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Figure Korea Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure Korea Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Figure India Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure India Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Figure Australia Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure Australia Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Table Europe Anticancer Drugs Consumption by Countries (2013-2018) (K Units)
Table Europe Anticancer Drugs Consumption Market Share by Countries (2013-2018)
Figure Europe Anticancer Drugs Consumption Market Share by Countries in 2017
Table Europe Anticancer Drugs Value by Countries (2013-2018) ($ Millions)
Table Europe Anticancer Drugs Value Market Share by Countries (2013-2018)
Figure Europe Anticancer Drugs Value Market Share by Countries in 2017
Table Europe Anticancer Drugs Consumption by Type (2013-2018) (K Units)
Table Europe Anticancer Drugs Consumption Market Share by Type (2013-2018)
Figure Europe Anticancer Drugs Consumption Market Share by Type in 2017
Table Europe Anticancer Drugs Consumption by Application (2013-2018) (K Units)
Table Europe Anticancer Drugs Consumption Market Share by Application (2013-2018)
Figure Europe Anticancer Drugs Consumption Market Share by Application in 2017
Figure Germany Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure Germany Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Figure France Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure France Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Figure UK Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure UK Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Figure Italy Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure Italy Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Figure Russia Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure Russia Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Figure Spain Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure Spain Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Anticancer Drugs Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Anticancer Drugs Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Anticancer Drugs Consumption Market Share by Countries in 2017
Table Middle East & Africa Anticancer Drugs Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Anticancer Drugs Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Anticancer Drugs Value Market Share by Countries in 2017
Table Middle East & Africa Anticancer Drugs Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Anticancer Drugs Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Anticancer Drugs Consumption Market Share by Type in 2017
Table Middle East & Africa Anticancer Drugs Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Anticancer Drugs Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Anticancer Drugs Consumption Market Share by Application in 2017
Figure Egypt Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure Egypt Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Figure South Africa Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure South Africa Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Figure Israel Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure Israel Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Figure Turkey Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure Turkey Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Anticancer Drugs Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Anticancer Drugs Value Growth 2013-2018 ($ Millions)
Table Anticancer Drugs Distributors List
Table Anticancer Drugs Customer List
Figure Global Anticancer Drugs Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Anticancer Drugs Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Anticancer Drugs Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Anticancer Drugs Consumption Market Forecast by Regions
Table Global Anticancer Drugs Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Anticancer Drugs Value Market Share Forecast by Regions
Figure Americas Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Americas Anticancer Drugs Value 2018-2023 ($ Millions)
Figure APAC Anticancer Drugs Consumption 2018-2023 (K Units)
Figure APAC Anticancer Drugs Value 2018-2023 ($ Millions)
Figure Europe Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Europe Anticancer Drugs Value 2018-2023 ($ Millions)
Figure Middle East & Africa Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Middle East & Africa Anticancer Drugs Value 2018-2023 ($ Millions)
Figure United States Anticancer Drugs Consumption 2018-2023 (K Units)
Figure United States Anticancer Drugs Value 2018-2023 ($ Millions)
Figure Canada Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Canada Anticancer Drugs Value 2018-2023 ($ Millions)
Figure Mexico Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Mexico Anticancer Drugs Value 2018-2023 ($ Millions)
Figure Brazil Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Brazil Anticancer Drugs Value 2018-2023 ($ Millions)
Figure China Anticancer Drugs Consumption 2018-2023 (K Units)
Figure China Anticancer Drugs Value 2018-2023 ($ Millions)
Figure Japan Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Japan Anticancer Drugs Value 2018-2023 ($ Millions)
Figure Korea Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Korea Anticancer Drugs Value 2018-2023 ($ Millions)
Figure Southeast Asia Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Southeast Asia Anticancer Drugs Value 2018-2023 ($ Millions)
Figure India Anticancer Drugs Consumption 2018-2023 (K Units)
Figure India Anticancer Drugs Value 2018-2023 ($ Millions)
Figure Australia Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Australia Anticancer Drugs Value 2018-2023 ($ Millions)
Figure Germany Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Germany Anticancer Drugs Value 2018-2023 ($ Millions)
Figure France Anticancer Drugs Consumption 2018-2023 (K Units)
Figure France Anticancer Drugs Value 2018-2023 ($ Millions)
Figure UK Anticancer Drugs Consumption 2018-2023 (K Units)
Figure UK Anticancer Drugs Value 2018-2023 ($ Millions)
Figure Italy Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Italy Anticancer Drugs Value 2018-2023 ($ Millions)
Figure Russia Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Russia Anticancer Drugs Value 2018-2023 ($ Millions)
Figure Spain Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Spain Anticancer Drugs Value 2018-2023 ($ Millions)
Figure Egypt Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Egypt Anticancer Drugs Value 2018-2023 ($ Millions)
Figure South Africa Anticancer Drugs Consumption 2018-2023 (K Units)
Figure South Africa Anticancer Drugs Value 2018-2023 ($ Millions)
Figure Israel Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Israel Anticancer Drugs Value 2018-2023 ($ Millions)
Figure Turkey Anticancer Drugs Consumption 2018-2023 (K Units)
Figure Turkey Anticancer Drugs Value 2018-2023 ($ Millions)
Figure GCC Countries Anticancer Drugs Consumption 2018-2023 (K Units)
Figure GCC Countries Anticancer Drugs Value 2018-2023 ($ Millions)
Table Global Anticancer Drugs Consumption Forecast by Type (2018-2023) (K Units)
Table Global Anticancer Drugs Consumption Market Share Forecast by Type (2018-2023)
Table Global Anticancer Drugs Value Forecast by Type (2018-2023) ($ Millions)
Table Global Anticancer Drugs Value Market Share Forecast by Type (2018-2023)
Table Global Anticancer Drugs Consumption Forecast by Application (2018-2023) (K Units)
Table Global Anticancer Drugs Consumption Market Share Forecast by Application (2018-2023)
Table Global Anticancer Drugs Value Forecast by Application (2018-2023) ($ Millions)
Table Global Anticancer Drugs Value Market Share Forecast by Application (2018-2023)
Table F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure F. Hoffmann-La Roche Ltd Anticancer Drugs Market Share (2016-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly and Company Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Eli Lilly and Company Anticancer Drugs Market Share (2016-2018)
Table CELGENE CORPORATION Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CELGENE CORPORATION Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CELGENE CORPORATION Anticancer Drugs Market Share (2016-2018)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis AG Anticancer Drugs Market Share (2016-2018)
Table Pfizer Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Inc Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Inc Anticancer Drugs Market Share (2016-2018)
Table Amgen Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Inc Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Amgen Inc Anticancer Drugs Market Share (2016-2018)
Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer AG Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bayer AG Anticancer Drugs Market Share (2016-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AstraZeneca Anticancer Drugs Market Share (2016-2018)
Table Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Takeda Pharmaceutical Company Limited Anticancer Drugs Market Share (2016-2018)
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck & Co. Anticancer Drugs Market Share (2016-2018)